Glycemic and Insulinemic Response of Pasta Products in Comparison to Asian Foods

NCT ID: NCT03646812

Last Updated: 2023-08-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-10

Study Completion Date

2020-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to determine the glycaemic and insulinaemic index of pasta products and local foods. It is hypothesized that different pasta cuts and wholegrain composition of pasta and local foods have different GI depending on the nature of the carbohydrate content and the food structure within each food.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There will be a total of 9 test sessions and each session will last up to 3.5 hours. The order of sessions will be determined with an online randomizer. At each test session, the following procedures will be performed: two finger-prick blood samples, five minutes apart to measure baseline blood glucose and insulin concentrations Subject will be served the test food and to consume within15 minutes Following the test meal, blood samples will be collected at the following time points: 15, 30, 45, 60, 90, 120, 150 and 180min for glucose measurements and insulin measurements will be collected at 30, 60, 90, 120, 150 and 180min.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Glucose Reference 1

50g of glucose dissolved in 250ml of water to be consumed.

Group Type OTHER

Glucose Reference 1

Intervention Type OTHER

Glucose contains 50g of available carbohydrates

Glucose Reference 2

50g of glucose dissolved in 250ml of water to be consumed.

Group Type OTHER

Glucose Reference 2

Intervention Type OTHER

Glucose contains 50g of available carbohydrates

Glucose Reference 3

50g of glucose dissolved in 250ml of water to be consumed.

Group Type OTHER

Glucose Reference 3

Intervention Type OTHER

Glucose contains 50g of available carbohydrates

Semolina Penne

70g of semolina penne boiled in 1 Litre of water for 11 minutes. Drained and consume immediately.

Group Type EXPERIMENTAL

Semolina Penne

Intervention Type OTHER

Semolina Penne contains 50g of available carbohydrates

Wholegrain Penne

76g of wholegrain penne boiled in 1 Litre of water for 9 minutes. Drained and consume immediately.

Group Type EXPERIMENTAL

Wholegrain Penne

Intervention Type OTHER

Wholegrain Penne contains 50g of available carbohydrates

Semolina Spaghetti

71g of semolina spaghetti boiled in 1 Litre of water for 8 minutes. Drained and consume immediately.

Group Type EXPERIMENTAL

Semolina Spaghetti

Intervention Type OTHER

Semolina Spaghetti contains 50g of available carbohydrates

Wholegrain Spaghetti

76g of wholegrain spaghetti boiled in 1 Litre of water for 8 minutes. Drained and consume immediately.

Group Type EXPERIMENTAL

Wholegrain Spaghetti

Intervention Type OTHER

Wholegrain Spaghetti contains 50g of available carbohydrates

Jasmine rice

63g of rice cook with 150g of water. Served and consume immediately.

Group Type EXPERIMENTAL

Jasmine Rice

Intervention Type OTHER

Jasmine Rice contains 50g of available carbohydrates

Asian Noodles

92.4g of Asian Noodles cook in boiling water for 45 seconds. Drained and consume immediately

Group Type EXPERIMENTAL

Asian Noodles

Intervention Type OTHER

Asian Noodles contains 50g of available carbohydrates

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glucose Reference 1

Glucose contains 50g of available carbohydrates

Intervention Type OTHER

Glucose Reference 2

Glucose contains 50g of available carbohydrates

Intervention Type OTHER

Glucose Reference 3

Glucose contains 50g of available carbohydrates

Intervention Type OTHER

Semolina Penne

Semolina Penne contains 50g of available carbohydrates

Intervention Type OTHER

Wholegrain Penne

Wholegrain Penne contains 50g of available carbohydrates

Intervention Type OTHER

Semolina Spaghetti

Semolina Spaghetti contains 50g of available carbohydrates

Intervention Type OTHER

Wholegrain Spaghetti

Wholegrain Spaghetti contains 50g of available carbohydrates

Intervention Type OTHER

Jasmine Rice

Jasmine Rice contains 50g of available carbohydrates

Intervention Type OTHER

Asian Noodles

Asian Noodles contains 50g of available carbohydrates

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy Asian - Indian and Chinese ethnicity
* Age between 21-40 years
* Body mass index between 18.5 to 25 kg/m2
* Normal blood pressure (\<140/90 mmHg)
* Fasting blood glucose \< 6 mmol/L

Exclusion Criteria

* Is a current smoker
* Is currently pregnant
* Have any metabolic diseases (such as diabetes, hypertension etc)
* Have known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
* Have medical conditions and/or taking medications known to affect glycemia(glucocorticoids, thyroid hormones, thiazide diuretics)
* Have any major organ dysfunction (e.g. cardiovascular, respiratory, hepatic, renal, gastrointestinal) that may influence taste, olfaction, appetite, digestion, metabolism, absorption or elimination of test foods, nutraceutical or drug
* Have any severe food allergy (e.g. anaphylaxis to peanuts)
* Have any known allergies to any food components of the study protocol
* Have active Tuberculosis (TB) or currently receiving treatment for TB
* Have any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
* Is a study team member or an immediate family of any study team member. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
* enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study.
* Have partake in sports at the competitive and/or endurance levels
* Have intentionally restrict food intake
Minimum Eligible Age

21 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Barilla Singapore Pte Ltd

UNKNOWN

Sponsor Role collaborator

Singapore Institute of Food and Biotechnology Innovation

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Nutrition Research Centre

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018/00622

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.